Cerulea Clinical Trials delivers ophthalmic clinical trials for Australian and international biopharmaceutical and medtech companies – and is the home of investigator-initiated studies for the Centre for Eye Research Australia (CERA).
We are a fully owned, not-for-profit subsidiary of CERA and share its vision of a world free from vision loss and blindness.
Company Details
- Employees
- 17
- Founded
- -
- Address
- 32 Gisborne St, Level 7,royal Victorian Eye And Ear Hospital,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Clinical Trials, Clinical research, Ophthalmology, medical research, clinical development, biotechnology, medical devices, gene therapy, biopharma pharmaceuticals.
- HQ
- East Melbourne, Victoria
Cerulea Clinical Trials Questions
Cerulea Clinical Trials's website is https://ceruleaclinicaltrials.org.au/
Cerulea Clinical Trials's LinkedIn profile is https://au.linkedin.com/company/cerulea-clinical-trials
Cerulea Clinical Trials has
17 employees.
View email and phone details for 17
employees at Cerulea Clinical Trials.
Cerulea Clinical Trials's industry is
Biotechnology Research
Cerulea Clinical Trials's top competitors are
Kinoxis Therapeutics Pty Ltd,
Momentum Clinical Research,
Alithia Life Sciences,
Novotech,
Accelagen Pty Ltd,
Centre For Eye Research Australia (Cera),
Doherty Clinical Trials,
Enersol,
Avance Clinical,
Praxis Australia Ltd.
Cerulea Clinical Trials's categories are Biotechnology Research
Cerulea Clinical Trials's founding year is 2023
